Kocián J
Institutu pro dalsí vzdĕlávání lékarů a farmaceutů Praha.
Vnitr Lek. 1992 Apr;38(4):352-6.
A group of 61 diabetics (incl. 35 treated by diet alone and 26 who were treated also by oral antidiabetics) with associated osteomalacia were treated with vitamin D (dosage 42,000 to 85,000 i. u. per day) and calcium (470-700 mg/day). After six weeks of this treatment the serum calcium level rose on average by 0.15 mmol/l and the blood sugar level declined on average by 1.68 mmol/l. A linear negative correlation was proved between these two parameters. The fasting blood sugar level declined in 53 subjects (86.88%) and only in five patients (8.19%) the blood sugar level increased, in three subjects (4.91%) it did not change. Possible explanations of this phenomenon include the influence of an increased calcium concentration on insulin secretion and release from pancreatic beta-cells on the one hand and enhanced glucose utilization in the periphery on the other hand.
一组61名伴有骨软化症的糖尿病患者(包括35名仅接受饮食治疗的患者和26名同时接受口服降糖药治疗的患者)接受了维生素D(剂量为每天42,000至85,000国际单位)和钙(每天470 - 700毫克)的治疗。经过六周的这种治疗后,血清钙水平平均升高了0.15毫摩尔/升,血糖水平平均下降了1.68毫摩尔/升。这两个参数之间被证明存在线性负相关。53名受试者(86.88%)的空腹血糖水平下降,只有5名患者(8.19%)的血糖水平升高,3名受试者(4.91%)的血糖水平没有变化。这种现象的可能解释包括,一方面,钙浓度升高对胰岛素分泌以及从胰腺β细胞释放的影响,另一方面,外周组织中葡萄糖利用率的提高。